Relyea Zuckerberg Hanson LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 1793691 STAMFORD, CT

Position in OCUL

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$172,832

+$23,760 QoQ

Shares Held

17,600

0.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#179

of 257 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Relyea Zuckerberg Hanson LLC holds $814,528 across 3 Biotechnology names. OCUL ranks #2 (21.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,157	$574,716
2	OCUL	Ocular Therapeutix, Inc This page	17,600	$172,832
3	ELDN	Eledon Pharmaceuticals, Inc.	17,000	$66,980

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$172,832	17,600	0.0%	Shares	Sole	2026-07-16
2026-03-31	$149,072	17,600	0.0%	Shares	Sole	2026-04-30
2025-12-31	$213,664	17,600	0.0%	Shares	Sole	2026-01-20
2025-09-30	$205,744	17,600	0.0%	Shares	Sole	2025-10-21
2025-06-30	$163,328	17,600	0.0%	Shares	Sole	2025-07-22
2025-03-31	$129,008	17,600	0.0%	Shares	Sole	2025-04-16
2024-12-31	$150,304	17,600	0.0%	Shares	Sole	2025-01-15
2024-09-30	$153,120	17,600	0.0%	Shares	Sole	2024-10-17
2024-06-30	$120,384	17,600	0.0%	Shares	Sole	2024-10-31
2024-03-31	$160,160	17,600	0.0%	Shares	Sole	2024-10-31
2023-12-31	$78,496	17,600	—	Shares	Sole	2024-10-31
No filing history on record for this holder in this stock.